Qulipta (atogepant)

pCPA File Number: 22394
Negotiation Status:
Concluded with an LOI
Indication(s):
For the prevention of episodic migraine in adults
Sponsor/Manufacturer:
AbbVie Corporation
CADTH Project Number:
SR0724
pCPA Engagement Letter Issued:
Negotiation Process Concluded: